PPT-Isolation of Rare Circulating Tumor Cells

Sunitha Nagrath et al httpwwwnibibnihgovnewseventsnewsroomcirculatingtumorcellscapturedlast Presentation by Keara Darragh Matthew Faw and Will Plautz Overview of Metastasis. Circulating Tumor Cells (CTC). Metastasis. : the spread of cancer from its primary site to other places in the body..  Metastatic disease is the most common cause of cancer-related death in patients with solid tumors.. Colin Reisterer and Nick Swenson. S. . Maheswaran. et al. . The New England Journal of Medicine. . 2007. http://www.all-cancer-treatments.com/types-of-lung-cancer.html. Clinical background: Non-small cell lung cancer (NSCLC). Nagrath. & . Sequist. et al. (2007). Journal Presentation. Brigitte Morales & Leanna Morinishi. December 8. th. , 2011. Nagrath. , S., . Sequist. , L. et al. Nature 450.7173 (2007):1235-239. Print.. AmirAli H. Talasaz, Ashley A. Powell, David E. Huber, James G. Berbee, Kyung-Ho Roh, Wong Yu, Wenzhong Xiao, Mark M. Davis, R. Fabian Pease, Michael N. Mindrinos, Stefanie S. Jeffrey, and Ronald W. Davis. By: . Weigang. . wang. , . sumanta. . goswami. , Erik . sahai. , . jeffrey. . b. . wyckoff. , Jeffrey E. . Segall. and John S. . Condeelis. Presented By: Lana . Awad. and Sebastian Lukjan. Motivation of research, why they did what they did…. c. aught in the act of invading: Their strategy for enhanced cell motility” . By Xinqi Li and Megan Roytman. Weigang . Wang, . Sumanta . Goswami, . Erik . Sahai, . Jeffrey B. . Wyckoff, . Jeffrey E. . Arshed A. Quyyumi, MD . Professor of Medicine . Emory Clinical Cardiovascular Research Institute (ECCRI). Emory University School of Medicine. Atlanta, GA. Grant support: . National Institutes of Health, . SUPERVISOR. 趙大中醫師. Breast Cancer. The most prevalent cancer in female. Mortality 4. th. in Taiwan. Treatment of Breast Cancer. Breast Cancer. When to change regimen?. Unacceptable toxicity. Marwan . Saoud. MD, . Kassem Harris MD, FCCP. Co-Chair. : WABIP Rare Lung, Pleura & Airway Disorders. Background. Rare Airway Tumors (RATs). . Tracheobronchial tumors that have not been extensively studied in . At diagnosis 80% of patients will present with metastasis.. Only 20% of these cases are clinically detectable.. Current imaging modalities are expensive and only detect established secondary tumors.. Youn Wha Kim Sung Wan Kim Yong-Koo Park Chondromyxoid fibroma (CMF) is a relatively rare bone tumorthat was first described by Jaffe and Lichtensteinin 1948. Thistumor makes up less than 1% of all bon Prepared by Kurt Schaberg MD Germ Cell Tumors 3 main subtypes depending on age and if they are derived from germ cell neoplasia in situ (GCNIS ). Most common: Germ cell tumors derived from GCNIS (Pos The market for circulating tumour cells is primarily driven by the rising understanding of
their diagnostic and clinical utility, which has prompted an increase in circulating tumour cell research in
an effort to develop efficient diagnostic tools. Intervista a Federico . Cappuzzo. Background:. Programmed death-ligand 1 (PD-L1) expression on tumor cells (TC) or tumor-infiltrating immune cells (IC) is associated with OS, PFS and ORR in pts with advanced NSCLC treated with atezolizumab (anti-PDL1, MPDL3280A; Spigel et al, Spira et al, ASCO 2015), indicating that PD-L1 expression on both TC and IC is important for anti-tumor immunity. However, these 2 distinct expression patterns suggest the existence of previously unidentified NSCLC subtypes with distinct immunologic profiles. .